Related Experiment Videos
Experimental studies with Stronglyloides papillosus in goats
J G Pienaar1, P A Basson, J L du Plessis
1Regional Veterinary Laboratory, Potgietersrus, South Africa.
The Onderstepoort Journal of Veterinary Research
|January 13, 2000
Summary
Experimental Strongyloides papillosus infections in goats revealed young animals are most susceptible to severe anemia and neurological signs. Acquired immunity develops but can be overcome by high parasite doses.
Area of Science:
- Veterinary Parasitology
- Animal Pathology
Background:
- Strongyloides papillosus infections in goats and sheep present unusual clinical and pathological findings.
- Field observations prompted experimental investigations into the parasite's effects.
Purpose of the Study:
- To experimentally infect goats with Strongyloides papillosus to characterize clinical signs, pathological changes, and immunity.
- To determine the susceptibility of different age groups of goats.
Main Methods:
- Goats of various ages were infected percutaneously with different doses of S. papillosus larvae.
- Clinical signs, pathological lesions, and acquired immunity were monitored.
- Clinicopathological parameters, including trace element levels, were analyzed.
Main Results:
- Young goats (up to 12 months) were most susceptible, exhibiting diarrhea, anemia, neurological signs, and cachexia.
- Pathological changes included enteritis, brain lesions (status spongiosus), liver rupture, nephrosis, and pneumonia.
- Acquired immunity was observed, indicated by skin reactions, but could be overcome by high larval doses.
- Anemia and hypophosphatemia were the most significant clinicopathological findings, with evidence of trace element deficiencies (Cu, Mn, Se).
Conclusions:
- Strongyloides papillosus infection poses a significant threat to young goats, causing severe clinical and pathological manifestations.
- Acquired immunity offers some protection but is not absolute against high parasite burdens.
- The study highlights the importance of considering trace element status in managing S. papillosus infections.